Mettler-Toledo International, Inc. $MTD Shares Sold by Bamco Inc. NY

Bamco Inc. NY reduced its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 30.8% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 146,334 shares of the medical instruments supplier’s stock after selling 65,018 shares during the quarter. Bamco Inc. NY owned about 0.72% of Mettler-Toledo International worth $204,017,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in the stock. Armistice Capital LLC boosted its position in shares of Mettler-Toledo International by 37.7% during the 4th quarter. Armistice Capital LLC now owns 340 shares of the medical instruments supplier’s stock worth $474,000 after purchasing an additional 93 shares in the last quarter. Freestone Grove Partners LP boosted its position in shares of Mettler-Toledo International by 10.2% during the 4th quarter. Freestone Grove Partners LP now owns 659 shares of the medical instruments supplier’s stock worth $919,000 after purchasing an additional 61 shares in the last quarter. Caisse de depot et placement du Quebec boosted its position in shares of Mettler-Toledo International by 114.4% during the 4th quarter. Caisse de depot et placement du Quebec now owns 36,649 shares of the medical instruments supplier’s stock worth $51,096,000 after purchasing an additional 19,552 shares in the last quarter. Schonfeld Strategic Advisors LLC boosted its position in shares of Mettler-Toledo International by 191.8% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 4,181 shares of the medical instruments supplier’s stock worth $5,829,000 after purchasing an additional 2,748 shares in the last quarter. Finally, DV Equities LLC purchased a new stake in shares of Mettler-Toledo International during the 4th quarter worth $40,000. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Barclays decreased their target price on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Morgan Stanley decreased their target price on shares of Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 12th. Citigroup decreased their target price on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. JPMorgan Chase & Co. decreased their target price on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a research report on Monday, May 11th. Finally, Wolfe Research assumed coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Six research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $1,408.55.

Mettler-Toledo International Trading Down 1.9%

NYSE:MTD opened at $1,129.97 on Thursday. The firm has a market cap of $22.83 billion, a price-to-earnings ratio of 26.50, a price-to-earnings-growth ratio of 2.40 and a beta of 1.27. The company’s 50-day moving average is $1,196.84 and its two-hundred day moving average is $1,305.29. Mettler-Toledo International, Inc. has a 12-month low of $1,023.05 and a 12-month high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. The company had revenue of $947.13 million for the quarter, compared to analyst estimates of $943.14 million. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. During the same period in the prior year, the firm earned $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, equities research analysts forecast that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.